Numbers first: cagrilintide · 0.9% sodium chloride.
I can predict the outcome but I cannot explain it, which means I will get the next case wrong.
I would like to know how confident the field actually is about this.
What is actually going on here, physically?
Concretely, gentle swirling dissolves a lyophilised cake far better than vigorous shaking, which causes aeration and aggregation.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|---|---|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsOn the detail: reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
The caveat on all of this is that it assumes the vial contains what the label says.
Do the arithmetic twice, ideally with someone else doing it independently.
Put another way, add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Number of stopper piercings matters less than the gauge doing the piercing.
One limitation: technique reduces risk, it does not remove it.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
If the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.
Check the barrel marking, not your memory of it.
Worth saying: if your arithmetic and someone else's disagree by a factor of ten, one of you has made a unit error.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
Do the arithmetic twice, ideally with someone else doing it independently.
edited 14 Oct 2025 by lane_transit — tightened the wording; no substantive change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.